"All of the things to everyone everywhere": A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19.

"All of the things to everyone everywhere": A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19.

Show other versions (1)

<h4>Background</h4>Neutralizing monoclonal antibody (mAb) treatment for COVID-19 prevents hospitalization and death but is underused, especially in racial/ethnic minority and rural populations. Reasons for underuse and inequity may include community member lack of awareness or healthcare...

Full description

Bibliographic Details
Main Authors: Bethany M Kwan, Chelsea Sobczak, Carol Gorman, Samantha Roberts, Vanessa Owen, Matthew K Wynia, Adit A Ginde, Griselda Pena-Jackson, Owen Ziegler, Lisa Ross DeCamp
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0274043

Internet

https://doi.org/10.1371/journal.pone.0274043

Similar Items